The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 47%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $15.
Sandridge Energy Inc
SD · the NYSE · USD · Market cap $503M · 102 employees
SandRidge Energy, Inc.
Not yet scoredPrice as of 18 Nov 2026Daily close, not a live quote
Screened 2026-11-18 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price12.19 USD at the 18 Nov 2026 close
- Fair value13.80. Our model only; only one analyst covers it, too few to cross-check it.
- Our value readUndervalued vs our fair value, as of 18 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 4.44)
- Last reviewed18 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $13.50 to $15.74, base estimate $13.80 (screen dated 2026-11-18).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 4.44, read 2026-11-19
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Sandridge Energy Inc holds its Distribution at $12.19. Elevated stress, defensive posture warranted, held for 3 days.
| Phase | Distribution · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 3 days |
| Price at the screen | $12.19 |
| Valuation | 6.91 trailing · 9.50 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.50 |
Five Screens: SD's Results
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | Excluded | Below 33% | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 21.56% | Below 49% | Pass |
| Revenue purity | 2.65% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadThe Read, in Plain English
Sandridge Energy clears the business-activity screen and the figures we can measure look clean, but its debt figure is still pending, so the verdict is not final yet.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Our model only; only one analyst covers it, too few to cross-check it.
Our analysis reads Undervalued vs our fair value, as of 18 Nov 2026: it trades at roughly a 12% discount to our $13.80 fair value, none competitive moat, 16.80% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-18 screen. The gold marker is the market price at the same screen. A 11.7% discount to the base estimate.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $13.80, with a range of $13.50 to $15.74, dated to the 2026-11-18 screen.
How our estimate and third-party targets differ.
The Business, in Plain Words| Forward P/E | 9.5xcheap for a company growing this fast |
| Trailing P/E | 6.9xvery cheap relative to earnings |
| EPS, trailing | 2.05 |
| EPS, forward | 1.49 |
| Revenue growth | +16.8%steady growth |
| Profit margin | 46.4%highly profitable on every dollar of sales |
| Return on equity | 15.3%a solid return on shareholder capital |
| FCF yield | -1.28% |
| Dividend yield | 3.71% |
| Debt to equity | 0.32minimal debt: a conservative balance sheet |
| Current ratio | 2.40comfortably covers its short-term bills |
| Beta | 0.50barely tracks the market's swings |
| Short interest, float | 0.06% |
| 52-week range | 9.89 - 18.45 |
| Moat | NONE |
| Market cap | $503M |
| Employees | 102 |
SD-specific watchpoints · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 47%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $15.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 7.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 47%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 47%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 47%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 47%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 47%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 47%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 47%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 47%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $14.35 | -15.1% | · | $850 | -15.1% |
| 2 months | $14.16 | -13.9% | · | $861 | -13.9% |
| 3 months | $14.34 | -15.0% | · | $850 | -15.0% |
| 6 months | $15.16 | -19.6% | $0.13 | $813 | -18.7% |
| 1 year | $13.90 | -12.3% | $0.58 | $919 | -8.1% |
| 2 years | $10.81 | +12.8% | $1.04 | $1,224 | +22.4% |
| 3 years | $11.62 | +4.9% | $2.98 | $1,306 | +30.6% |
| 5 years | $8.23 | +48.1% | $5.18 | $2,111 | +111.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SD does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.